TipRanks
Go Ultimate55% OFF

Infant Bacterial Therapeutics AB (9IB) Cash flow

Infant Bacterial Therapeutics AB Cash Flow

DE:9IB's free cash flow for Q2 2026 was $-23.19M. For the 2026 fiscal year, DE:9IB's free cash flow was increased by $0.00 and operating cash flow was $-23.19M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -72.34M$ -113.13M$ -101.22M$ -85.80M$ -55.62M
$ 0.00$ 0.00$ -4.15M$ -1.00K$ 0.00
$ 0.00$ 2.01M$ 96.52M$ 1.88M$ 91.00K
$ 144.01M$ 223.39M$ 329.06M$ 335.84M$ 386.75M
$ -72.34M$ -113.13M$ -101.22M$ -85.80M$ -55.62M

Currency in SEK

Infant Bacterial Therapeutics AB Cash Flow

-200M-100M0100M200M300M400M500M201720182019202020212022202320242025OperatingInvestingFinancing